Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psilocybin in the Treatment of Methamphetamine Use Disorder

NCT07774702 is registered in ClinicalTrials.gov with Peter Hendricks as lead sponsor.

NCT NCT07774702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07774702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psilocybin in the Treatment of Methamphetamine Use Disorder
Lead sponsor
Peter Hendricks
Phase
Phase 2
Overall status
Not yet recruiting
Start date
February 1, 2027
Completion date
February 1, 2032
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine use disorder